|
Dr. Jim A. Wright has extensive experience in cancer research drug development and biotechnology. For example he was a cofounder of the biotechnology company GeneSense Technologies Inc. with Dr. Aiping H. Young and at various times he served as a member of the Board Chairman of the Board Corporate Secretary President and Chief Scientific Officer of Lorus (the "Company"). Dr. Wright entered Lorus following the merger of GeneSense Technologies and Lorus Technologies in October 1999. Dr. Wright is also recognized internationally for his work in cancer biology. He has been a Professor of Microbiology in the Faculty of Science a Professor of Biochemistry and Molecular Biology in the Faculty of Medicine and an Adjunct Professor of Internal Medicine in the Faculty of Medicine at the University of Manitoba. He has also been Senior Scientist of the Manitoba Institute of Cell Biology Manitoba Cancer Treatment and Research Foundation and has served as the Associate Director and also the Acting Director of the Manitoba Institute of Cell Biology Manitoba Cancer Treatment and Research Foundation. He has also held the position of Professor of Medical Biophysics at the University of Toronto. Dr. Wright has been a Terry Fox Scientist a Senior Scientist of the National Cancer Institute of Canada and up until recently he has been a Terry Fox Senior Scientist of the National Cancer Institute of Canada. Dr. Wright has published approximately 200 scientific papers and has co-authored numerous patent applications. He has served as an advisor for various journals agencies and companies. | 